FR EN

Back


13/09/2011
AM-Pharma Raises $40M Series D
AM-Pharma NV, a Dutch developer of Alkaline Phosphatase for treatment of severe inflammatory diseases, has closed on 29.2 million euro in a Series D financing round led by Ysios Capital Partners. Venture funds BB Biotech Ventures, Idinvest Partners, Forbion Capital Partners and Inventages Venture Capital also joined in on the round...
Read more on PEHub.com




X

X

X